These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Dopamine D1 and D2 receptors in progressive supranuclear palsy: an autoradiographic study. Pascual J, Berciano J, Grijalba B, del Olmo E, González AM, Figols J, Pazos A. Ann Neurol; 1992 Nov; 32(5):703-7. PubMed ID: 1449252 [Abstract] [Full Text] [Related]
4. Organization of dopamine D1 and D2 receptors in human striatum: receptor autoradiographic studies in Huntington's disease and schizophrenia. Joyce JN, Lexow N, Bird E, Winokur A. Synapse; 1988 Nov; 2(5):546-57. PubMed ID: 2973147 [Abstract] [Full Text] [Related]
6. Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution. Piggott MA, Marshall EF, Thomas N, Lloyd S, Court JA, Jaros E, Burn D, Johnson M, Perry RH, McKeith IG, Ballard C, Perry EK. Brain; 1999 Aug; 122 ( Pt 8)():1449-68. PubMed ID: 10430831 [Abstract] [Full Text] [Related]
7. Genetic inactivation of dopamine D1 but not D2 receptors inhibits L-DOPA-induced dyskinesia and histone activation. Darmopil S, Martín AB, De Diego IR, Ares S, Moratalla R. Biol Psychiatry; 2009 Sep 15; 66(6):603-13. PubMed ID: 19520364 [Abstract] [Full Text] [Related]
8. Changes of D1 and D2 dopamine receptor mRNA in the brains of monkeys lesioned with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: correction with chronic administration of L-3,4-dihydroxyphenylalanine. Morissette M, Goulet M, Calon F, Falardeau P, Blanchet PJ, Bédard PJ, Di Paolo T. Mol Pharmacol; 1996 Nov 15; 50(5):1073-9. PubMed ID: 8913337 [Abstract] [Full Text] [Related]
9. Dopamine D3 receptor is decreased and D2 receptor is elevated in the striatum of Parkinson's disease. Ryoo HL, Pierrotti D, Joyce JN. Mov Disord; 1998 Sep 15; 13(5):788-97. PubMed ID: 9756147 [Abstract] [Full Text] [Related]
10. Striatal dopaminergic terminals in type 1 and type 2 alcoholics measured with [3H]dihydrotetrabenazine and human whole hemisphere autoradiography. Tupala E, Häkkinen M, Storvik M, Tiihonen J. Psychiatry Res; 2008 May 30; 163(1):70-5. PubMed ID: 18394867 [Abstract] [Full Text] [Related]
11. Phenotypical characterization of the neurons expressing the D1 and D2 dopamine receptors in the monkey striatum. Aubert I, Ghorayeb I, Normand E, Bloch B. J Comp Neurol; 2000 Feb 28; 418(1):22-32. PubMed ID: 10701753 [Abstract] [Full Text] [Related]
12. Striatal D1 and D2 dopamine receptor loss in asymptomatic mutation carriers of Huntington's disease. Weeks RA, Piccini P, Harding AE, Brooks DJ. Ann Neurol; 1996 Jul 28; 40(1):49-54. PubMed ID: 8687191 [Abstract] [Full Text] [Related]
14. Loss of synaptic D1 dopamine/N-methyl-D-aspartate glutamate receptor complexes in L-DOPA-induced dyskinesia in the rat. Fiorentini C, Rizzetti MC, Busi C, Bontempi S, Collo G, Spano P, Missale C. Mol Pharmacol; 2006 Mar 28; 69(3):805-12. PubMed ID: 16365282 [Abstract] [Full Text] [Related]
15. What has been learnt from study of dopamine receptors in Parkinson's disease? Hurley MJ, Jenner P. Pharmacol Ther; 2006 Sep 28; 111(3):715-28. PubMed ID: 16458973 [Abstract] [Full Text] [Related]
16. Abnormal dopamine uptake sites in postmortem striatum from patients with Tourette's syndrome. Singer HS, Hahn IH, Moran TH. Ann Neurol; 1991 Oct 28; 30(4):558-62. PubMed ID: 1838678 [Abstract] [Full Text] [Related]
17. Differential expression of D1 and D2 dopamine and m4 muscarinic acetylcholine receptor proteins in identified striatonigral neurons. Ince E, Ciliax BJ, Levey AI. Synapse; 1997 Dec 28; 27(4):357-66. PubMed ID: 9372558 [Abstract] [Full Text] [Related]
20. Loss of dopamine D2 receptors in Alzheimer's disease with parkinsonism but not Parkinson's or Alzheimer's disease. Joyce JN, Murray AM, Hurtig HI, Gottlieb GL, Trojanowski JQ. Neuropsychopharmacology; 1998 Dec 28; 19(6):472-80. PubMed ID: 9803423 [Abstract] [Full Text] [Related] Page: [Next] [New Search]